- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01886703
Feasibility of a Walking Program for Cancer Survivors Receiving Radiation Therapy (PEDWAY)
May 1, 2017 updated by: Margie McNeely, University of Alberta
Feasibility of a Supported Walking Program for Breast and Head-and-Neck Cancer Survivors Receiving Adjuvant Radiation Therapy
This pilot study will assess whether a supported pedometer-based walking program is helpful in maintaining physical activity for breast and head-and-neck cancer patients who are undergoing radiation therapy.
Follow-up monitoring sessions will be scheduled to help provide support for physical activity during radiation therapy.
We will also examine the relationship of physical activity and quality of life outcomes to help inform future research.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Will the integration of a patient-centered exercise prescription and supportive counseling attenuate declines in physical activity during radiation therapy?
To address this question, this study will assess the feasibility of a patient-centered walking program for breast and head-and-neck cancer patients undergoing radiation therapy.
Follow-up monitoring sessions will be scheduled to help provide support and ongoing counseling to facilitate increased activity (through walking) during radiation therapy.
We will also examine the effect of the walking program on other outcomes such as happiness, depression and sleep to determine point estimates and measures of variability to inform future research.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6J4P9
- Cross Cancer Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Survivors with a diagnosis of breast cancer or head and neck cancer
- Adults aged 18 years or older
- Commencing adjuvant radiation therapy treatments
- Karnofsky Performance Status greater than or equal to 60%
Exclusion Criteria:
- Clinical or radiological evidence of active disease, either local or metastatic
- Serious non-malignant disease, such as cardiac failure or advanced arthritis of weight bearing joints, which would preclude daily treatment and follow-up
- Patients for whom physical activity or exercise is contraindicated
- Psychiatric or addictive disorders which preclude obtaining informed consent or adherence to the protocol
- Unable to comply with the protocol, measurement and follow-up schedule (e.g., scheduling conflicts, time commitment)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Walking Intervention
Pedometer Walking Program
|
All subjects will be prescribed a low-intensity walking program based on their current activity level and an daily assigned step count goal (with the current physical activity recommendations of 30 minutes of moderate-to-vigorous activity per day or 150 minutes per week as the ideal goal).
Participants will be provided with face-to-face counseling and written material describing their specific individualized walking program.
Participants will also be instructed to maintain their normal activities as much as possible during the intervention period.
Participants will be given a pedometer and instructed to wear it at least 5 days per week for the duration of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Accrual Rate and Completion Rate
Time Frame: Anticipated duration of radiation therapy of 6 weeks
|
Accrual: Number of participants agreeing to participate divided by the number of eligible participants Completion rate: number of participants completing the trial
|
Anticipated duration of radiation therapy of 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence
Time Frame: Anticipated duration of radiation therapy of 6 weeks
|
Adherence to the intervention protocol: number of days meeting target step count
|
Anticipated duration of radiation therapy of 6 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6-Minute Walk Test
Time Frame: Change from baseline to anticipated end of radiation therapy of 6 weeks
|
The six-minute walk test (6MWT) measures the distance an individual is able to walk over a six minutes time period on a hard, flat surface (e.g., 100 foot hallway).
|
Change from baseline to anticipated end of radiation therapy of 6 weeks
|
Physical Activity
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
An accelerometer armband will be used to provide a breakdown of an individual's daily activity.
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Self-esteem
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Rosenberg Self-Esteem Scale (10 item)
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Depression
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Beck Depression Inventory II (21 item)
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Happiness
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Oxford Happiness Questionnaire (29 items)
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Sleep
Time Frame: Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Pittsburgh Sleep Quality Index (9 item)
|
Change from baseline to anticipated duration of radiation therapy of 6 weeks
|
Fatigue
Time Frame: Recorded daily during study period of 6 weeks
|
Visual analogue scale, recorded as part of daily diary
|
Recorded daily during study period of 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Margaret McNeely, PhD, University of Alberta and Cross Cancer Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
June 16, 2013
First Submitted That Met QC Criteria
June 25, 2013
First Posted (Estimate)
June 26, 2013
Study Record Updates
Last Update Posted (Actual)
May 3, 2017
Last Update Submitted That Met QC Criteria
May 1, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ACREC 26059
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
No plan in place
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
University of Texas, El PasoNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingPhysical Activity | Activity TrackersUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
University of Colorado, DenverCompletedPhysical Activity | Physical ImpairmentUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
AdventHealth Translational Research InstituteWake Forest UniversityRecruiting
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
Clinical Trials on Pedometer Walking Program
-
National Defense Medical Center, TaiwanMinistry of Science and Technology, TaiwanCompletedExercise | Happiness | Educational Problems
-
Mansoura UniversityRecruitingFatigue | Physical InactivityEgypt
-
Albert Einstein College of MedicineCompletedCervical Cancer | Head and Neck Cancer | Lung Cancer | Brain Cancer | Gastrointestinal CancerUnited States
-
US Department of Veterans AffairsCompletedCardiovascular Diseases | Hypertension | Obesity | Diabetes Mellitus | HyperlipidemiaUnited States
-
Rigshospitalet, DenmarkNovo Nordisk A/S; Copenhagen University Hospital at Herlev; Danish Cancer Society and other collaboratorsCompleted
-
Arizona State UniversityKarolinska InstitutetCompleted
-
University of GlasgowCompleted
-
University Hospital, MontpellierRecruitingHypertension, PulmonaryFrance
-
Boston CollegeCompleted
-
Boston University Charles River CampusCompletedParkinson DiseaseUnited States